您的购物车当前为空
MONNA 是 TMEM16A (Anoctamin-1)阻滞剂,IC50为 80 nM。它在氯离子存在或不存在的情况下诱导啮齿动物抵抗动脉的血管舒张。


为众多的药物研发团队赋能,
让新药发现更简单!
MONNA 是 TMEM16A (Anoctamin-1)阻滞剂,IC50为 80 nM。它在氯离子存在或不存在的情况下诱导啮齿动物抵抗动脉的血管舒张。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 362 | In Stock | |
| 5 mg | ¥ 892 | In Stock | |
| 10 mg | ¥ 1,320 | In Stock | |
| 25 mg | ¥ 2,880 | In Stock | |
| 50 mg | ¥ 4,360 | In Stock | |
| 100 mg | ¥ 6,190 | 待询 | |
| 200 mg | ¥ 8,480 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 678 | In Stock |
MONNA 相关产品
| 产品描述 | MONNA is a potent TMEM16A (Anoctamin-1) blocker (IC50 : 80 nM). It induces vasorelaxation of rodent resistance arteries in presence or absence of chloride ions. |
| 靶点活性 | TMEM16A:80 nM |
| 体外活性 | The TMEM16A-specific inhibitor, MONNA, hyperpolarised the membrane potential in U46619.?MONNA, T16Ainh -A01, and Ani9 attenuated 5-HT/U46619-induced contractions.?MONNA and T16Ainh -A01 also increased coronary flow in Langendorff perfused rat heart preparations.?TMEM16A mRNA was increased in coronary artery smooth muscle cells from SHRs, and U46619 and 5-HT were more potent in arteries from SHRs than in those from normal Wistar rats.?MONNA diminished this increased sensitivity to U46619 and 5-HT[1]. |
| 分子量 | 338.31 |
| 分子式 | C18H14N2O5 |
| CAS No. | 1572936-83-4 |
| Smiles | COc1cc(Nc2ccc(cc2C(O)=O)[N+]([O-])=O)cc2ccccc12 |
| 密度 | 1.421 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 25 mg/mL (73.9 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容